Endocrinology, Vol 124, 1097-1099, Copyright © 1989 by Endocrine Society

ARTICLES

Human parathyroid hormone carboxyterminal peptide (53-84) stimulates alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma cells in vitro

TM Murray, LG Rao, SA Muzaffar and H Ly
Division of Endocrinology and Metabolism, St. Michael's Hospital, Toronto, Ontario, Canada.

Previous studies in our laboratory have demonstrated relatively large numbers of cell surface binding sites for the carboxylterminal (53-84) region of PTH on ROS 17/2.8 rat osteosarcoma cells, a clonal osteoblast- like cell line. In order to gain insight into the significance of these carboxylterminal binding sites, we studied the effect of intact bovine PTH (1-84), its aminoterminal fragment bovine PTH (1-34), and the human PTH carboxylterminal fragment (53-84) on alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma (ROS) 17/2.8 cells. While bovine PTH (1-84) and its aminoterminal 1-34 fragment inhibited alkaline phosphatase activity, we saw a dose-related stimulation of activity by human PTH (53-84), with maximal stimulation occurring after 120 hours, at a concentration of 10(-8) M. The effect was not seen in dexamethasone-untreated cells. To our knowledge, this is the first published demonstration of biological activity of this carboxylterminal PTH peptide, previously thought to be inactive. It is likely that dexamethasone caused differentiation of cells to a type more sensitive to human PTH (53-84). Further studies are necessary to elucidate the physiological significance of these findings.

This article has been cited by other articles:

				J. Jolette, C. E. Wilker, S. Y. Smith, N. Doyle, J. F. Hardisty, A. J. Metcalfe, T. B. Marriott, J. Fox, and D. S. Wells Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1-84 in a 2-Year Study in Fischer 344 Rats Toxicol Pathol, December 1, 2006; 34(7): 929 - 940. [Abstract] [PDF]

				T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF]

				L. Nguyen-Yamamoto, L. Rousseau, J.-H. Brossard, R. Lepage, and P. D’amour Synthetic Carboxyl-Terminal Fragments of Parathyroid Hormone (PTH) Decrease Ionized Calcium Concentration in Rats by Acting on a Receptor Different from the PTH/PTH-Related Peptide Receptor Endocrinology, April 1, 2001; 142(4): 1386 - 1392. [Abstract] [Full Text]

				A. K. Harvey, X.-P. Yu, C. A. Frolik, and S. Chandrasekhar Parathyroid Hormone-(1-34) Enhances Aggrecan Synthesis via an Insulin-like Growth Factor-I Pathway J. Biol. Chem., August 13, 1999; 274(33): 23249 - 23255. [Abstract] [Full Text] [PDF]

				A. J. Koh, C. A. Beecher, T. J. Rosol, and L. K. McCauley 3',5'-Cyclic Adenosine Monophosphate Activation in Osteoblastic Cells: Effects on Parathyroid Hormone-1 Receptors and Osteoblastic Differentiation in Vitro Endocrinology, July 1, 1999; 140(7): 3154 - 3162. [Abstract] [Full Text]

				H. Takasu and F. R. Bringhurst Type-1 Parathyroid Hormone (PTH)/PTH-Related Peptide (PTHrP) Receptors Activate Phospholipase C in Response to Carboxyl-Truncated Analogs of PTH(1-34) Endocrinology, October 1, 1998; 139(10): 4293 - 4299. [Abstract] [Full Text] [PDF]

				B. h. Sun, M. Mitnick, C. Eielson, G. Q. Yao, I. Paliwal, and K. Insogna Parathyroid Hormone Increases Circulating Levels of Fibronectin in Vivo: Modulating Effect of Ovariectomy Endocrinology, September 1, 1997; 138(9): 3918 - 3924. [Abstract] [Full Text] [PDF]

				A. Hollnagel, D. Schroder, and G. Gross Domain-specific Gene Activation by Parathyroid Hormone in Osteoblastic ROS17/2.8 Cells J. Biol. Chem., September 6, 1996; 271(36): 21870 - 21877. [Abstract] [Full Text] [PDF]

				A. Azarani, D. Goltzman, and J. Orlowski Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936. [Abstract] [Full Text] [PDF]